KSB TUGEN
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $3.6M
Investors
- 4
About KSB TUGEN
, Ltd. operates as a pharmaceutical company that focuses on conducting research and development for the treatment of muscle-related diseases., Ltd., Ltd. is a developer of therapeutics designed to provide treatment for intractable sarcopenia based on clinical multi-omics. The company's therapeutics provide senile sarcopenia treatment that helps to fight against diseases, enabling healthcare companies to provide patients with treatment solutions.
Who invested in KSB TUGEN
4 investors across 2 rounds
See all investors in KSB TUGEN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KSB TUGEN
Who invested in KSB TUGEN?
KSB TUGEN has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KSB TUGEN raised?
KSB TUGEN has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did KSB TUGEN last raise money?
KSB TUGEN's most recent round on record is a Series B, in Oct 2025.
What does KSB TUGEN do?
KSB TUGEN is a healthcare company.
Where is KSB TUGEN headquartered?
KSB TUGEN is headquartered in Chungju, South Korea.
Which VCs invest in companies like KSB TUGEN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at KSB TUGEN's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like KSB TUGEN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.